Oncology PET Scan Coverage Expands As CMS Lifts Some Data Mandates
This article was originally published in The Gray Sheet
Executive Summary
Medicare coverage of PET scans for oncology indications will be less restrictive under a national coverage determination finalized April 3
You may also be interested in...
CMS Urged To Lift All Evidence-Development Restrictions On PET For Solid Tumors
Move to lift coverage-with-evidence-development restrictions is widely supported by industry, medical specialty societies and clinicians.
News In Brief
Welch Allyn restructuring to cut jobs by 10% over three years. Neurovision v. NuVasive update. CMS opens coverage analysis on PET for solid tumors. More news briefs.
Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says
A broad range of stakeholders is asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.